Skip to main content
BMC Pulmonary Medicine logoLink to BMC Pulmonary Medicine
. 2018 Apr 25;18:62. doi: 10.1186/s12890-018-0625-5

Improved heart hemodynamics after draining large-volume pleural effusion: a prospective cohort study

Zheng Wang 1,#, Qi-Zhe Cai 2,#, Cheng-Jun Ban 1, Duo Chen 1, Li-Li Xu 1, Xiao-Juan Wang 1, Zhen Wang 1, Yuan Yang 1, Xiu-Zhang Lv 2, Huan-Zhong Shi 1,
PMCID: PMC5921556  PMID: 29699542

Abstract

Background

Pleural effusion (PE) drainage can relieve the symptoms of dyspnea; however, details of the resulting hemodynamic changes remain undefined.

Methods

Subjects older than 12 years with massive PE requiring pleural drainage were included in this study. Hemodynamic parameters were collected using transthoracic echocardiography at pre-drainage, immediately post-drainage, and 24 h after drainage.

Results

We enrolled 47subjects in this prospective study from June 9, 2015 to September 18, 2016 in Beijing Chaoyang Hospital and 28 subjects were analyzed finally. Draining large-volume PE led to a progressive increase in left ventricular end-diastolic volume index, left atrial volume index, right ventricular area, right atrial area, left ventricular ejection fraction, stroke volume, and tricuspid annular plane systolic excursion, both immediately (P < 0.05) and 24 h after drainage (P < 0.05). The cardiac diastolic measurement ratios of early-transmitral flow velocity to diastolic mitral annular velocity and myocardial performance index decreased significantly following drainage (P < 0.05). More parameters were influenced by left-sided PE drainage. The correlation between effusion volume and changes in echocardiographic measurements was not statistically significant.

Conclusions

Improved preload, and systolic and diastolic function is pivotal for hemodynamic change after draining large PE volumes. Subjects experienced improved cardiac hemodynamics following PE drainage, underlining the beneficial therapeutic and subjective effects.

Electronic supplementary material

The online version of this article (10.1186/s12890-018-0625-5) contains supplementary material, which is available to authorized users.

Keywords: Large-volume pleural effusion, Drainage, Hemodynamic, Transthoracic echocardiography

Background

Large-volume pleural effusion (PE) is a common complication causing breathlessness, and patients often experience dramatic and immediate relief from dyspnea after therapeutic thoracentesis [1]. Although it is a well-recognized phenomenon, the detailed mechanism underlying witnessed improvements following drainage remains poorly understood [2]. The reasons for breathlessness caused by PE maybe multifactorial, but improvements in pulmonary mechanics do not explain the degree of relief following thoracentesis [3].

Previous studies have focused on the effects of PE on cardiovascular hemodynamics. Case reports have shown that PE can cause circulatory instability and hemodynamic compromise through a mechanism resembling cardiac tamponade [4, 5]. An early animal model study supported this phenomenon [6]. Other investigators have proposed that drainage after pleurocentesis may contribute to cardiac preload improvement and hemodynamic optimization in large-volume PE patients [7]. However, exactly when the hemodynamic change is most obvious remains unknown; therefore, evaluating the effect of drainage on the cardiovascular system at different points in time may be beneficial and may contribute to understanding the resulting dyspnea relief.

The aim of this prospective study was to assess the effects of drainage of large-volume PE and changes in cardiac function at different time points, then to compare the hemodynamic measurements between PE on different sides of the thorax.

Methods

This study was approved by the Ethics Committee of Beijing Chaoyang Hospital and conducted in agreement with the Helsinki II declaration. Written informed consent was obtained from all participants. Approval was obtained from the Beijing Chao-Yang Hospital Institutional Review Board (approval number: 2016–2–19–9), and the clinical trial number is NCT02548221.

Subjects

We assessed the eligibility of all PE patients who visit the department of Respiratory and Critical Care Medicine in Beijing Chaoyang Hospital and required pleural drainage for the treatment of breathlessness.

Inclusion criteria: 1. Subjects with symptomatic PE secondary to non-cardiac etiology who required pleural drainage as part of standard clinical management of the effusion. 2. No drainage was performed within 1 month before admission. 3. Written informed consent was obtained.

Exclusion criteria: 1) Subjects with physical weakness making drainage difficult to endure; 2) Subjects who had undergone drainage within 1 month before admission; 3) We excluded subjectswith pericardial effusion because the pericardial effusion may have confounded our results [8].

Drainage procedure

All drainage procedures were performed by the same trained pulmonologist using standard protocol. Thoracentesis, indwelling pleural catheters,or medical thoracoscopy was chosen for pleural opening to perform large-volume drainage. Thoracentesis was performed with echocardiographic evaluation immediately after drainage, and a second echocardiographic examination was performed 24 h later. The medical thoracoscopy procedure and equipment have been described previously [9, 10]. Pleural biopsies were collected for diagnostic confirmation of the cause of the PE, and we recorded the PE characteristics, including the volume and appearance, etiology and details of any prior pleural procedures.

Transthoracic echocardiography(TTE)

All subjects were evaluated by comprehensive TTEby Dr. Xiu-zhang LV and Qi-Zhe Cai according to the American Society of Echocardiography [11] at three time points: prior to drainage (baseline), immediately after, and 24 h after drainage. Both the two doctors were blinded to the three time points assignment. Echocardiographic images were acquired using an EPIQ 7C scanner (Philips Medical Systems, Bothell, WA) with a matrix-array transducer (X5–1). The specific methods are included in the Additional file 1.

Briefly, we used three-and two-dimensional quantification to quantify chamber volumes: end-diastolic and end-systolic left ventricular (LV)volume, ejection fraction and stroke volume (SV),left atrial, LV end-diastolic volume index (LVdVI), LV end-systolic volume index (LVsVI), and left atrial volume index (LAVI).These volume values were divided by the body surface index for each patient. Right ventricular (RV) and right atrial (RA) areas were evaluated in apical four-chamber views. Right ventricular systolic function was evaluated by fractional area change (FAC) and tricuspid annular plane systolic excursion (TAPSE). Mitral and tricuspid valve velocities were recorded as E, A, and TvE, TvA, respectively. E/A and TvE/A were the ratio of E over A and the ratio of TvE over TvA, respectively. Annular velocities of the mitral and tricuspid valves were analyzed by tissue Doppler image and recorded as Em, Am, and Et. E/Em and TvE/Et were the ratios of E over Em and TvE over Et, respectively. LV isovolumic relaxation time and RV myocardial performance index (MPI) were also recorded. Global left ventricular strain (GLS) and right ventricular free-wall strain (RVFWs) were derived from two-dimensional speckle tracking images.

Statistical analysis

Comparisons were performed using Wilcoxon’s test according to the distribution of the data. We used Pearson’s χ2 test to test for differences in distribution of categorical variables between groups with PE on different sides of the thorax. Differences in parameters when comparing data immediately after thoracentesis or 24 h after thoracentesis with baseline were assessed using Wilcoxon’s test. To explore whether the parameter was maintained, enhanced, or lost 24 h after drainage, we compared data from immediately after drainage with the 24-h data using Wilcoxon’s test (paired difference test).To test for correlations among variables, we used Spearman’s correlation test, and we created a scatter plot to demonstrate the significant correlations. All P-values were two-sided, and P < 0.05 was considered statistically significant. All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS 13.0, Chicago, IL).

Results

Characteristics of the study population

Forty-seven subjects were included in the study from June 9, 2015 to September 18, 2016 in Beijing Chaoyang Hospital, and the side distribution of drained PE was 23 (48.9%)left-sided and 24 (51.1%)right-sided. There were no significant differences in baseline values for age, smoking status, medical history, body surface area, effusion volume, and effusion appearance between the two groups (Table 1). There were significant differences in gender and Nt-pro BNP between left- and right-sided effusion groups, with P < 0.022 and 0.004 respectively. Table 2 shows the etiologies of the PE.

Table 1.

Subjects’ characteristics

Variables Total Lateral of effusion, n (%) P* value
Left Right
Subjects, n(%) 47 (100.0) 23 (48.9) 24 (51.1)
Gender, n (%)
 Female 18 (38.3) 5 (21.7) 13 (54.2) 0.022
 Male 29 (61.7) 18 (78.3) 11 (45.8)
Age, yr., mean ± SD 56.4 ± 19.5 52.6 ± 19.0 63.1 ± 17.3 0.726
BSA, mean ± SD 1.73 ± 0.19 1.83 ± 0.16 1.63 ± 0.17 0.582
Smoking status, n (%)
 Current or previous smoker 18 (38.3) 6 (26.1) 12 (50.0) 0.092
 Non-smoker 29 (61.7) 17 (73.9) 12 (50.0)
Past history
 Tuberculosis 4 (8.5) 3 (13.0) 1 (4.2) 0.546
 Malignancy 4 (8.5) 2 (8.7) 2 (8.3)
 NA 39 (83.0) 18 (78.3) 21 (87.5)
Size of effusion, n (%)
 Small 8 (17.0) 3 (13.0) 5 (20.8) 0.696
 Moderate 9 (19.1) 4 (17.4) 5 (20.8)
 Large 30 (63.9) 16 (69.6) 14 (58.3)
volume of effusion, (ml)
 Total volume 2142.2 ± 1393.7 2194.6 ± 1511.1 2203.6 ± 1301.8 0.827
 Immediate volume 1414.4 ± 727.9 1384.8 ± 982.0 1495.2 ± 947.6 0.744
 24 h volume 943.6 ± 742.8 809.8 ± 787.2 708.4 ± 708.0 0.855
Effusion appearance, n (%)
 Bloody 20 (42.5) 11 (47.8) 9 (37.5) 0.474
 Yellow 27 (57.5) 12 (52.2) 15 (62.5)
Operation
 IPC 15 (31.9) 8 (34.8) 7 (29.2) 0.893
 Thoracentesis 10 (21.3) 5 (21.7) 5 (20.8)
 thoracoscopic 22 (46.8) 10 (43.5) 12 (50.0)
Pre Nt-pro-BNP (ng/ml) 221.3 ± 316.5 126.7 ± 176.6 320.2 ± 396.5 0.004

Abbreviations: SD standard deviation, IPC indwelling pleural catheter

P*, Wilcoxon’s test or Pearson’s χ2 test, P < 0.05

Table 2.

Causes of pleural effusion

Cause n, %
Malignancies 24 (51.1)
Primary lung cancer 14 (29.8)
Secondary carcinoma 2 (4.3)
Mesothelioma 4 (8.5)
Lymphoma 1 (2.1)
Undetermined 3 (6.4)
Benign diseases 23 (48.9)
Tuberculosis 17 (36.0)
Non-specific pleurisy 2 (4.3)
Other transudate 2 (4.3)
Other exudates 2 (4.3)
Total 47 (100.0)

The mean volume of removed fluid was 2142.2 ± 1393.7 mL. We excluded 14subjectsbecause of a lack of data from: baseline (n = 6), immediately after drainage(n = 5), or 24 h after drainage(n = 3).Five subjects were also excluded because of atrial fibrillation (n = 1) or poor three-dimensional echocardiography data (n = 4). A final 28 subjects were enrolled with 13 left- and 15 right-sided PE. No Nt-pro BNP difference was found between left and right when looking at just 28 analyzed subjects (data not shown).

Overall influence of PE on cardiac hemodynamics

The influence of PE on cardiac hemodynamics was evaluated by comparing differences in real-time parameters with echocardiographic measurements. The preload parameters, LVdVI, LAVI, RV area, and RA area increased significantly both immediately after drainage and 24 h after drainage (P < 0.05). LVsVI improved significantly only at 24 h after drainage. Similarly, the systolic measurements, LVEF, SV, and TAPSE, increased significantly at bothpost-drainage time points (P < 0.05). GLS and RVFWs increased 24 h after drainage (P < 0.05) but not immediately post-drainage (P > 0.05). In contrast, the LV diastolic measurements, E/Em and A (late transmitral flow velocity), decreased24 hours after drainage. MPI, representing RV diastolic function, decreased significantly(P < 0.05). Significant differences between values immediately after and 24-h after drainage were seen for LVdVI, SV, and TAPSE(P < 0.05). The other variables showed no significant changes during the measurement periods (see Table 3).

Table 3.

Real-time echocardiographic changes in hemodynamics before and after pleural drainage

Parameters Effusion (n = 28)
Before Immediately After P a 24 h After P b P c
Left Heart
 LVdVI, (ml/m2) 31.9 (24.3–42.8) 35.3 (31.3–44.9) < 0.001 36.7 (31.1–48.2) < 0.001 0.019
 LVsVI, (ml/m2) 11.3 (9.4–16.7) 12.2 (10.2–16.3) 0.220 12.2 (10.3–15.2) < 0.001 0.264
 LAVI, (ml/m2) 22.8 (17.2–26.0) 26.5 (19.1–29.7) 0.018 27.4 (22.9–32.0) < 0.001 0.234
Right Heart
 RV area, (cm2) 14.1 (12.5–18.9) 17.3 (15.2–18.9) 0.036 17.3 (15.0–18.5) 0.011 0.782
 RA area, (cm2) 11.8 (9.9–14.9) 14.1 (11.3–16.3) 0.016 14.2 (11.3–15.6) 0.018 0.727
Left ventricle
 LVEF, (%) 62.0 (59.3–66.8) 65.0 (63.0–68.8) 0.030 68.5 (64.0–71.0) 0.008 0.071
 SV, (ml) 36.0 (27.3–47.5) 41.0 (35.5–49.8) < 0.001 42.5 (38.0–52.6) < 0.001 0.006
 Sm, (cm/s) 8.2 (7.5–9.7) 8.0 (7.5–9.3) 0.952 9.0 (8.0–9.6) 0.137 0.055
 GLS, (%) 19.0 (18.0–20.0) 19.5 (18.0–21.0) 0.086 21.0 (18.0–22.9) < 0.001 0.029
Right ventricle
 FAC, (%) 45.5 (38.3–52.0) 48.0 (45.0–57.0) 0.065 50.0 (40.0–55.0) 0.347 < 0.001
 TAPSE, (cm) 18.0 (17.0–19.8) 20.1 (19.0–22.0) < 0.001 22.4 (19.5–24.8) 0.001 < 0.001
 RVFWs, (%) 18.0 (17.6–19.3) 19.1 (18.3–21.5) 0.137 19.3 (18.3–21.1) 0.018 0.603
Left ventricle
 IVRT, (s) 106.0 (106.0–127.0) 113.0 (106.0–123.0) 0.601 118.0 (106.0–135.3) 0.310 0.649
 E, (cm/s) 74.5 (67.8–85.0) 70.7 (64.3–76.8) 0.285 64.8 (56.8–82.4) 0.178 0.683
 A, (cm/s) 85.5 (63.8–113.8) 91.9 (58.7–103.3) 0.493 80.8 (48.9–93.4) 0.019 0.058
 E/A 0.9 (0.7–1.1) 0.8 (0.7–1.3) 0.546 0.9 (0.7–1.3) 0.260 0.157
 Em, (cm/s) 7.0 (6.1–9.8) 7.4 (6.3–8.7) 0.819 8.4 (6.2–9.3) 0.170 0.170
 Am, (cm/s) 10.4 (8.9–11.7) 10.9 (10.0–12.1) 0.390 11.0 (10.4–12.6) 0.334 0.309
 E/Em 10.9 (7.1–13.6) 9.8 (7.3–11.0) 0.419 9.1 (6.4–10.6) 0.023 0.095
Right ventricle
 MPI 0.7 (0.6–0.7) 0.5 (0.5–0.7) < 0.001 0.5 (0.4–0.6) 0.002 0.585
 TvE, (cm/s) 54.0 (45.0–65.3) 57.0 (50.3–65.9) 0.536 53.0 (46.2–64.8) 0.543 0.065
 TvA, (cm/s) 51.5 (40.8–60.3) 48.7 (40.8–60.3) 1.000 41.8 (35.9–51.5) 0.069 0.027
 TvE/A 1.1 (0.8–1.3) 1.2 (0.8–1.4) 0.619 1.3 (1.1–1.4) 0.122 0.265
 TvE/Et 4.2 (3.6–5.8) 4.5 (3.1–4.9) 0.339 3.5 (2.8–5.4) 0.264 0.406

Abbreviations: LVdVI Left ventricular end diastolic volume index, LVsVI left ventricular end-systolic volume index, LAVI left atrial volume index, RV area, right ventricular area, RA area, right atrial area, LVEF left ventricular ejection fraction, SV stroke volume, Sm systolic mitral annular velocity, GLS global left ventricular strain, FAC fractional area change, TAPSE, tricuspid annular plane systolic excursion, RVFWs right ventricular free-wall strain, E early-transmitralflow velocity, A late-transmitral flow velocity, E/A, ratio of early- to late-transmitral flow velocity, Em, early-diastolic mitral annular velocity, Am late-diastolic mitral annular velocity, E/Em ratio of early-transmitral flow velocity to diastolic mitral annular velocity, MPI, myocardial performance index, TvE early-transtricuspid flow velocity, TvA late-transtricuspid flow velocity;TvE/A, ratio of early- to late-transtricuspid flow velocity, TvE/Et, ratio of early-transtricuspid flow velocity to diastolic tricuspid annular velocity

*Pa < 0.05 compared with the corresponding parameters before and immediately after drainage; Pb < 0.05 compared with the corresponding parameters before and 24 h after drainage;Pc < 0.05 compared with the corresponding value immediately after drainage and the value 24 h after drainage

Subgroup analysis of PE influence on cardiac hemodynamics based on left or right side

To explore whether different PE on different sides of the thorax has a distinct influence on cardiac function, we divided subjects into the PE subgroups, left-sided (n = 13) and right-sided (n = 15). Comparisons of the echocardiographic measurements in the subgroups appeared in Additional file 2 Tables S1, S2 and S3. Significant changes were observed for LVdVI, LVsVI, LAVI, RV area, SV, TAPSE, and MPI when data for both groups were pooled. Increases in LVEF, FAC, RVFWs, and TvE/A, and decreases in E/Em and TvA were significant in the left-sided group(P < 0.05). We also saw significant improvements in RA area and GLS after drainage in the right-sided group (P < 0.05).

For left-sided PE, LVdVI, SV, TAPSE, RVFWs, MPI, and TvE/A changed significantly both immediately after and 24 h after drainage. For example, for SV (Fig. 1d), the median value increased from 42.0 ml at baseline to 46.0 ml immediately after drainage (Pa = 0.002), then to 51.4 ml 24 h after drainage (Pb = 0.002, Pc = 0.007).However, the median and quartile FAC ranges increased from 62.0% (60.0%–66.0%)of baseline to 64.0% (63.0%–65.0%) of baseline only immediately after drainage (Pa = 0.043); no changes were seen 24 h after drainage (Pb = 0.308, Pc = 0.107). Other measurements in the left-sided group also changed very little 24 h after drainage including LVsVI, LAVI, RV area, LVEF, E/Em, and TvA.

Fig. 1.

Fig. 1

ac shows the changes in LVdVI, stroke volume, and TAPSE at baseline, immediately after, and 24 h after drainage for the entire study population. d shows the changes instroke volume in the left- and right-sided effusion subgroups. LVdVI, left ventricular end diastolic volume index; SV, stroke volume; TAPSE, tricuspid annular plane systolic excursion

In the right-sided group, some measurements, including LVsVI, LAVI, and GLS increased only 24 h after drainage and were unchanged immediately after drainage. MPI changed very little immediately after drainage. Also in the right-sided group, the median RV area increased from 13.2cm2 at baseline to 18.2cm2 immediately after drainage (Pa = 0.005) then decreased to 17.3cm224 h after drainage (Pb = 0.008); no significant difference was seen between the immediately-after and 24 h-after data (Pc = 0.156).

Correlation between PE drainage volume and changes in echocardiographic measurements

Additional file 2 Table S4 shows the correlation between PE drainage volume and changes in echocardiographic measurements. We found no consistent relationship between PE volume and changes in echocardiographic measurements between different sides. We did see a positive influence of effusion volume on RA area parameters 24 h after drainage(r = 0.501)but without statistical significance (P = 0.057).

Discussion

Our research was a comprehensive study to discuss the relationship between PE drainage and echo cardiovascular parameters, including preload parameters, and systolic and diastolic measurements.

This study showed that drainage of large PE volumes led to an immediate increase in LVdVI, LAVI, RV area, and RA area for all enrolled subjects. While previous studies showed that removing large PE volumes may cause relative hypovolemia secondary to fluid redistribution to the pleural cavity [12], our results did not support these findings. More studies have shown improved left cardiac preload in both human [7] and porcine models [6], similar to our results. This improvement may be associated with the underlying mechanism in which PE increases pulmonary arterial resistance and pulmonary wedge pressure through vessel compression; RV afterload then increases and LV preload decreases. PE drainage may attenuate RV afterload and amplify LV preload. With lung expansion and recovery of collapsed alveoli, RV afterload decreases further while LV preload subsequently increases, which was confirmed by our results. Preload parameters, including LVdVI,increased24 h after drainage compared with immediately after drainage. This change may imply that improved hemodynamics may occur immediately and could be amplified with lung expansion, and may explain why the increased LVsVI reached statistical significance only 24 h after drainage.

Improved RA and RV areaimply that PE maybe responsible for collapse of the right heart, which was seen in a porcine model measuring central venous pressure(CVP), a surrogate marker for RV transmural pressure [6]. PE decreased CVP and right-lateral transmural pressure, which meant a decrease in RV end-diastolic volume. Therefore, PE drainage may lead to increased RV preload, also shown in several previous studies. Sadaniantz and co-authors showed that PE led to RA collapse [8], and Vaska and co-authors suggested that large-volume PE can increase intrapericardial pressure and cause RV diastolic collapse [13]. Therefore, based on Frank-Starling’slaw, if RVFAC increases, then heart beats after this effect can transmit to the LV. Although changes in FAC did not reach statistical significance, the median value tended to increase, in our study.

Also in our study, systolic function measured by LVEF, SV, and TAPSE improved after drainage, similar to end-diastolic volume(preload). This phenomenon can be explained by the Frank-Starling mechanism in that increased LV preload can result in increased SV within a range. However, ina study by Hermansen and co-authors, ejection fraction did not change after pleurocentesis [7]. Two underling reasons may explain this difference. First, the study suggested that changes in LV end-diastolic volume and LV end-systolic volume were inconstant. Although both LVdVI and LVsVI increased following drainage, LVdVI increase may have been greater than that of LVsVI, which causes a greater SV(SV = LVdV − LVsV), tending to increase LVEF (LVEF=SV/LVdV). Second, increased GLS and RVFWs may reflect increased myocardial contractility to increase both LVEF and FAC.

We interpreted decreased A, E/Em, and MPI as improved diastolic function. A previous study demonstrated that A, E, TvA, and TvE of tricuspid and mitral valves all decreased after thoracocentesis with unreliable results [14]. However, we observed a significant change for A only 24 h after drainage. This difference maybe because of poor echo windows, which reduced the accuracy of measurements in the previous study. A and E/Em are two of the principal deflections for assessing transmitral velocity patterns. Therefore, decreasing values can be used to predict decreasing LV filling pressures, which represent improved LV diastolic function. Heart rate may have an impact on transmitral flow pattern; therefore, we added MPI, in our study. Decreased MPI means improved RV diastolic function, and this fact supports the argument that PE may generate diastolic dysfunction.

In the study, the statistically-significant changes of some echo parameters were fairly small, such as LVEF, TAPSE. It may be asymptomatic and may do not have clinically meaning in healthy subjects who do not suffer from large volume of PE. But for patients with large volume of PE, the change may have some sub-clinical significance. This findings regarding the large-volume drainage –induced changes in echocardiographic parameters need to be confirmed in much larger and more heterogenous collectives of patients.

When dividing the population into subgroups of left and right sides of the thorax, we saw interesting results. Most of the preload and systolic parameters, except RA area and LVEF, improved for both sides. More parameters were influenced by left lateral PE, possibly because the presence of large-volume PE may have dissimilar impact on compliance on the different ventricles secondary to the different anatomical structures in the left and right heart. A recent study in ventilated animals investigated the relationship between cardiac impedance and intrathoracic pressure. PE decreased lung compliance and simultaneously increased chest wall compliance [15], but the authors did not discuss hemodynamic variables and ventricular compliance. Regarding the hemodynamic effects of PE, several studies demonstrated that large-volume PE may decrease compliance in the left ventricle while increasing pulmonary capillary wedge pressure and CVP, and reducing cardiac outputand arterial pressure [1618]. Brochand co-authors suggested that bilateral PE does not affect the ability of certain dynamic variables to predict fluid responsiveness in a porcine model [6]. However, neither of these studies compared the differences of echocardiographic measurements between two sides of PE.

We saw no dose-response relationship between PE volume and changes in cardiovascular hemodynamic measurements, which we did not expect, and which may reflect several important underlying reasons. First, the effect of PE on cardiovascular measurements may have many confounding factors, which can be controlled only in animal models through invasive measures. Second, the severity of breathlessness was poorly correlated with effusion volume. Previous studies concluded that effusion volume does not influence gas exchange and changes inPaO2 [19, 20], and a similar relationship between effusion volume and hemodynamic changes may also exit. Therefore, further studies with larger sample sizes are needed to determine whether PE volume definitively affects hemodynamics.

Due to poor quality data, some enrolled PE subjects were excluded from the final analysis. So we made a comparison between the enrolled and excluded subjects in baseline characteristics (data not shown) and found no significant differences between the groups. There is no apparent choosing bias in the methodology and the excluded subjects does not affect the final analysis.

Conclusions

Our study maybe one of the most comprehensive studies to address changes in basic hemodynamic determinants induced by PE drainage in people, based on TTE. Our results implied significant improvement in cardiac preload and systolic function with substantial improvement in diastolic function following drainage. To our knowledge, ours is the first study to divide PE subjects into left- and right-sided subgroups and to show that PE on different sides may have distinct influences on cardiac hemodynamics. Our findings do not support the hypothesis that higher drainage volumes cause a linear improvement in cardiac function. Our results indicated that improved cardiac hemodynamics are a considerable contributor to the underlying mechanisms causing dyspnea in PE patients. These findings may help illustrate how PE influences cardiac hemodynamics, which then helps determine the therapeutic approach to PE.

Additional files

Additional file 1: (14.8KB, docx)

Transthoracic echo cardiography(TTE). The specific methods describing how the cardiocalic paremeters were measured or calculated using the transthoracic echocardiography. (DOCX 14 kb)

Additional file 2: (35KB, docx)

Table S4. The changes of pre-load parameters by echocardiographic findings before and after drainage of subgroups of pleural effusions. Significant changes were observed on LVdVI for both laterals at both immediate and 24 hours drainage. But RV area and RA area were only observed to increase in the right group without alterations in the left PE. No significant differences were seen between the immediately after drainage and 24 hours after drainage data (with Pc > 0.05). Table S5. The changes of systolic functions by echocardiographic findings before and after drainage of subgroups of pleural effusions. Some systolic measurements, SV and TAPSA changed on both laterals at both time points. While increases in LVEF, FAC and RVFWs were significant only in the left group. In the right group, GLS increased only at 24 hours after drainage. Table S6 The changes of diastolic functions by echocardiographic findings before and after drainage of subgroups of pleural effusions. The diastolic parameter, MPI changed on both sides of PE. The increase in TvE/A and decreases in E/Em and TvA were significant merely in the left group. (DOCX 35 kb)

Acknowledgments

The authors gratefully acknowledge Dr. Ni Li for assistance with statistical analyses.

Funding

This work was supported in part by grants from the National Natural Science Foundation of China (No. 81600070, No. 91442109, and No. 31470883), in part by the Beijing Municipal Administration of Hospitals’ Mission Plan (No. SML20150301), and in part by the Chinese Ministry of Science and Technology for the establishment of GCP evaluation systems in respiratory diseases (2014ZX09303302).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

A

Late-peak mitral valve velocity

Am

Late-diastolic mitral annular velocity

E

Early-transmitral flow velocity

E/A

Ratio of early to late transmitral flow velocity

E/Em

Ratio of early transmitral flow velocity to diastolic-mitral annular velocity

EF

Ejection fraction

Em

Early-diastolic mitral annular velocity

FAC

Fractional area change

GLS

Global left ventricular strain

IVRT

Isovolumic relaxation time

LA

Left atrial

LAVI

Left atrial volume index

LV

Left ventricular

LVdVI

Left ventricular end-diastolic volume index

LVEF

Left ventricular ejection fraction

LVsVI

Left ventricular end-systolic volume index

MPI

Myocardial performance index

PE

Pleural effusion

RA area

Right atrial area

RV area

Right ventricular area

RVFWs

Right ventricular free wall strain

SV

Stroke volume

TAPSE

Tricuspid annular plane systolic excursion

TTE

Transthoracic echocardiography

TvA

Late-transtricuspid flow velocity

TvE

Early-transtricuspid flow velocity

TvE/A

Ratio of early to late transtricuspid flow velocity

TvE/Et

Ratio of early-transtricuspid flow velocity to diastolic-tricuspid annular velocity

Authors’ contributions

H-ZS designed the study, analyzed the data, and revised the manuscript. ZW and Q-ZC contributed equally to manuscript preparation, study design, data collection and analysis, and the main text composition. C-JB, DC, L-LX, X-JW, ZW, YY and X-ZL performed the clinical procedures. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The study was approved by the Ethics Committee of Beijing Chaoyang Hospital. All participants were consent to participate in this study. Written informed consent was obtained from all participants. For participants under 16 years old, the written informed consent was obtained from their parent or legal guardian. Approval was obtained from the Beijing Chao-Yang Hospital Institutional Review Board (approval number: 2016–2–19–9).

Competing interests

The authors declare that they have no competing interests exist with any companies/organizations whose products or services may be discussed in this article. None on financial conflict of interests exist.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Footnotes

Electronic supplementary material

The online version of this article (10.1186/s12890-018-0625-5) contains supplementary material, which is available to authorized users.

Contributor Information

Zheng Wang, Email: azheng178@163.com.

Qi-Zhe Cai, Email: echocaiqizhe@163.com.

Cheng-Jun Ban, Email: banchengjun@sina.com.

Duo Chen, Email: chenduozx2751@163.com.

Li-Li Xu, Email: lily_5809@qq.com.

Xiao-Juan Wang, Email: xjwang730715@sina.com.

Zhen Wang, Email: wz_0316@126.com.

Yuan Yang, Email: yangyuan361@126.com.

Xiu-Zhang Lv, Email: chaoyanglxz@163.com.

Huan-Zhong Shi, Phone: (86) 10 85231890, Email: shihuanzhong@sina.com.

References

  • 1.Mitrouska I, Klimathianaki M, Siafakas NM. Effects of pleural effusion on respiratory function. Can Respir J. 2004;11(7):499–503. doi: 10.1155/2004/496901. [DOI] [PubMed] [Google Scholar]
  • 2.Estenne M, Yernault JC, De Troyer A. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med. 1983;74(5):813–819. doi: 10.1016/0002-9343(83)91072-0. [DOI] [PubMed] [Google Scholar]
  • 3.Light RW, Stansbury DW, Brown SE. The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am Rev Respir Dis. 1986;133(4):658–661. doi: 10.1164/arrd.1986.133.4.658. [DOI] [PubMed] [Google Scholar]
  • 4.Kaplan LM, Epstein SK, Schwartz SL, Cao QL, Pandian NG. Clinical, echocardiographic, and hemodynamic evidence of cardiac tamponade caused by large pleural effusions. Am J Respir Crit Care Med. 1995;151(3 Pt 1):904–908. doi: 10.1164/ajrccm/151.3_Pt_1.904. [DOI] [PubMed] [Google Scholar]
  • 5.Kopterides P, Lignos M, Papanikolaou S, Papadomichelakis E, Mentzelopoulos S, Armaganidis A, et al. Pleural effusion causing cardiac tamponade: report of two cases and review of the literature. Heart Lung. 2006;35(1):66–67. doi: 10.1016/j.hrtlng.2005.07.001. [DOI] [PubMed] [Google Scholar]
  • 6.Broch O, Gruenewald M, Renner J, Meybohm P, Schöttler J, Heß K, et al. Dynamic and volumetric variables reliably predict fluid responsiveness in a porcine model with pleural effusion. PLoS One. 2013;8(2):e56267. doi: 10.1371/journal.pone.0056267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hermansen JF, Juhl-Olsen P, Frederiksen CA, Christiansen LK, Hørlyck A, Sloth E. Drainage of large pleural effusions increases left ventricular preload. J Cardiothorac Vasc Anesth. 2014;28(4):885–889. doi: 10.1053/j.jvca.2013.11.018. [DOI] [PubMed] [Google Scholar]
  • 8.Sadaniantz A, Anastacio R, Verma V, Aprahamian N. The incidence of diastolic right atrial collapse in patients with pleural effusion in the absence of pericardial effusion. Echocardiography. 2003;20(3):211–215. doi: 10.1046/j.1540-8175.2003.03017.x. [DOI] [PubMed] [Google Scholar]
  • 9.Wang F, Wang Z, Tong Z, Xu L, Wang X, Wu Y. A pilot study of autofluorescence in the diagnosis of pleural disease. Chest. 2015;147(5):1395–1400. doi: 10.1378/chest.14-1351. [DOI] [PubMed] [Google Scholar]
  • 10.Wang XJ, Yang Y, Wang Z, Xu LL, Wu YB, Zhang J, et al. Efficacy and safety of diagnostic thoracoscopy in undiagnosed pleural effusions. Respiration. 2015;90(3):251–255. doi: 10.1159/000435962. [DOI] [PubMed] [Google Scholar]
  • 11.Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39. doi: 10.1016/j.echo.2014.10.003. [DOI] [PubMed] [Google Scholar]
  • 12.Light RW, Jenkinson SG, Minh VD, George RB. Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis. Am Rev Respir Dis. 1980;121(5):799–804. doi: 10.1164/arrd.1980.121.5.799. [DOI] [PubMed] [Google Scholar]
  • 13.Vaska K, Wann LS, Sagar K, Klopfenstein HS. Pleural effusion as a cause of right ventricular diastolic collapse. Circulation. 1992;86(2):609–617. doi: 10.1161/01.CIR.86.2.609. [DOI] [PubMed] [Google Scholar]
  • 14.Chidambaram S, Sangareddi V, Ganesan G, Dhandapani VE, Ravi MS, Meenakshi K, et al. An echocardiographic assessment of cardiovascular hemodynamics in patients with large pleural effusion. Indian Heart J. 2013;65(6):666–670. doi: 10.1016/j.ihj.2013.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Graf J, Formenti P, Santos A, Gard K, Adams A, Tashjian J, et al. Pleural effusion complicates monitoring of respiratory mechanics. Crit Care Med. 2011;39(10):2294–2299. doi: 10.1097/CCM.0b013e3182227bb5. [DOI] [PubMed] [Google Scholar]
  • 16.Ahmed SH, Ouzounian SP, Dirusso S, Sullivan T, Savino J, Del Guercio L. Hemodynamic and pulmonary changes after drainage of significant pleural effusions in critically ill, mechanically ventilated surgical patients. J Trauma. 2004;57(6):1184–1188. doi: 10.1097/01.TA.0000145074.98431.15. [DOI] [PubMed] [Google Scholar]
  • 17.Lan CC, Hsu HH, Wu CP, Lee SC, Peng CK, Chang H. Influences of pleural effusion on respiratory mechanics, gas exchange, hemodynamics, and recruitment effects in acute respiratory distress syndrome. J Surg Res. 2014;186(1):346–353. doi: 10.1016/j.jss.2013.09.002. [DOI] [PubMed] [Google Scholar]
  • 18.Nishida O, Arellano R, Cheng DC, DeMajo W, Kavanagh BP. Gas exchange and hemodynamics in experimental pleural effusion. Crit Care Med. 1999;27(3):583–587. doi: 10.1097/00003246-199903000-00040. [DOI] [PubMed] [Google Scholar]
  • 19.Chang SC, Shiao GM, Perng RP. Postural effect on gas exchange in patients with unilateral pleural effusions. Chest. 1989;96(1):60–63. doi: 10.1378/chest.96.1.60. [DOI] [PubMed] [Google Scholar]
  • 20.Romero S, Martin C, Hernandez L, Arriero JM, Benito N, Gil J. Effect of body position on gas exchange in patients with unilateral pleural effusion: influence of effusion volume. Respir Med. 1995;89(4):297–301. doi: 10.1016/0954-6111(95)90091-8. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1: (14.8KB, docx)

Transthoracic echo cardiography(TTE). The specific methods describing how the cardiocalic paremeters were measured or calculated using the transthoracic echocardiography. (DOCX 14 kb)

Additional file 2: (35KB, docx)

Table S4. The changes of pre-load parameters by echocardiographic findings before and after drainage of subgroups of pleural effusions. Significant changes were observed on LVdVI for both laterals at both immediate and 24 hours drainage. But RV area and RA area were only observed to increase in the right group without alterations in the left PE. No significant differences were seen between the immediately after drainage and 24 hours after drainage data (with Pc > 0.05). Table S5. The changes of systolic functions by echocardiographic findings before and after drainage of subgroups of pleural effusions. Some systolic measurements, SV and TAPSA changed on both laterals at both time points. While increases in LVEF, FAC and RVFWs were significant only in the left group. In the right group, GLS increased only at 24 hours after drainage. Table S6 The changes of diastolic functions by echocardiographic findings before and after drainage of subgroups of pleural effusions. The diastolic parameter, MPI changed on both sides of PE. The increase in TvE/A and decreases in E/Em and TvA were significant merely in the left group. (DOCX 35 kb)

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.


Articles from BMC Pulmonary Medicine are provided here courtesy of BMC

RESOURCES